Spots Global Cancer Trial Database for skin squamous cell carcinoma

Every month we try and update this database with for skin squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS	NCT03822988	Advance Directi... Oncology Skin Cancer Melanoma Skin Lymphoma Skin Squamous C... Metastatic Basa...	no intervention...	18 Years -	Central Hospital, Nancy, France
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers	NCT06223659	Cutaneous Melan... Merkel Cell Car... Skin Squamous C...	Eutectic Mixtur... Placebo Adminis... Questionnaire A...	18 Years - 99 Years	Ohio State University Comprehensive Cancer Center
Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer	NCT02964559	Recurrent Skin ... Skin Squamous C...	Pembrolizumab	18 Years -	Emory University
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers	NCT02978625	Adenoid Cystic ... Adnexal Carcino... Anaplastic Larg... Anaplastic Larg... Apocrine Carcin... Cylindrocarcino... Digital Papilla... Endocrine Mucin... Extramammary Pa... Extraocular Cut... Hidradenocarcin... Keratoacanthoma Malignant Sweat... Merkel Cell Car... Microcystic Adn... NK-Cell Lymphom... Papillary Adeno... Porocarcinoma Primary Cutaneo... Recurrent Matur... Recurrent T-Cel... Refractory Anap... Refractory Matu... Refractory Merk... Refractory Myco... Refractory Prim... Refractory Skin... Refractory T-Ce... Sezary Syndrome Signet Ring Cel... Skin Basal Cell... Skin Basosquamo... Skin Squamous C... Spiradenocarcin... Squamoid Eccrin... Squamous Cell C... Sweat Gland Car... Trichilemmal Ca... Vulvar Squamous...	Biopsy Biospecimen Col... Computed Tomogr... Laboratory Biom... Nivolumab Positron Emissi... Talimogene Lahe...	18 Years -	National Cancer Institute (NCI)
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors	NCT03108131	Skin Squamous C... Appendix Adenoc... Rare Lesion Locally Advance... Locally Advance... Metastatic Mali... Metastatic Skin... Metastatic Smal... Rare Neoplastic... Refractory Mali... Stage IV Small ... Unresectable Ma...	Atezolizumab Cobimetinib	18 Years -	M.D. Anderson Cancer Center
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors	NCT05592626	Advanced Solid ... Genital Neoplas... Urogenital Neop... Lung Neoplasm Neoplasms by Si... Papillomavirus ... Epstein-Barr Vi... Carcinoma Neoplasms Vulvar Neoplasm... Vulvar Diseases Abdominal Neopl...	STAR0602	18 Years -	Marengo Therapeutics, Inc.
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers	NCT02978625	Adenoid Cystic ... Adnexal Carcino... Anaplastic Larg... Anaplastic Larg... Apocrine Carcin... Cylindrocarcino... Digital Papilla... Endocrine Mucin... Extramammary Pa... Extraocular Cut... Hidradenocarcin... Keratoacanthoma Malignant Sweat... Merkel Cell Car... Microcystic Adn... NK-Cell Lymphom... Papillary Adeno... Porocarcinoma Primary Cutaneo... Recurrent Matur... Recurrent T-Cel... Refractory Anap... Refractory Matu... Refractory Merk... Refractory Myco... Refractory Prim... Refractory Skin... Refractory T-Ce... Sezary Syndrome Signet Ring Cel... Skin Basal Cell... Skin Basosquamo... Skin Squamous C... Spiradenocarcin... Squamoid Eccrin... Squamous Cell C... Sweat Gland Car... Trichilemmal Ca... Vulvar Squamous...	Biopsy Biospecimen Col... Computed Tomogr... Laboratory Biom... Nivolumab Positron Emissi... Talimogene Lahe...	18 Years -	National Cancer Institute (NCI)
Oral Rigosertib for Squamous Cell Carcinoma	NCT01807546	Head and Neck S... Anal Squamous C... Lung Squamous C... Cervical Squamo... Esophageal Squa... Skin Squamous C... Penile Squamous...	rigosertib	18 Years -	Traws Pharma, Inc.
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors	NCT04234113	Thyroid Renal Cell Carc... Non Small Cell ... Small-cell Lung... Bladder Cancer Melanoma Merkel Cell Car... Skin Squamous C... Microsatellite ... Triple Negative... Mesothelioma Thymic Cancer Cervical Cancer Biliary Tract C... Hepatocellular ... Ovarian Cancer Gastric Cancer Head and Neck S... Anal Cancer	SO-C101 pembrolizumab	18 Years -	Sotio Biotech Inc.
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer	NCT03944941	Skin Squamous C... Metastatic Skin...	Avelumab Cetuximab	18 Years -	Alliance for Clinical Trials in Oncology
Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma (DaRT)	NCT03353077	Skin Squamous C...	Radiation: Diff...	18 Years -	Alpha Tau Medical LTD.
Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer	NCT00954226	Recurrent Head ... Recurrent Saliv... Recurrent Skin ... Skin Squamous C...	Erlotinib Hydro... Laboratory Biom...	18 Years -	M.D. Anderson Cancer Center
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer	NCT03944941	Skin Squamous C... Metastatic Skin...	Avelumab Cetuximab	18 Years -	Alliance for Clinical Trials in Oncology
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers	NCT06223659	Cutaneous Melan... Merkel Cell Car... Skin Squamous C...	Eutectic Mixtur... Placebo Adminis... Questionnaire A...	18 Years - 99 Years	Ohio State University Comprehensive Cancer Center
Oral Rigosertib for Squamous Cell Carcinoma	NCT01807546	Head and Neck S... Anal Squamous C... Lung Squamous C... Cervical Squamo... Esophageal Squa... Skin Squamous C... Penile Squamous...	rigosertib	18 Years -	Traws Pharma, Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: